Pharmacology of cardiovascular gap junctions

Advances in Cardiology

Volumn 42, Issue , 2006, Pages 107-131

  Hervé, Jean Claude ^a   Dhein, Stefan ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AAP 10; GAP JUNCTION PROTEIN; OLIGOPEPTIDE; ROTIGAPTIDE;

ANIMAL; CELL COMMUNICATION; CELL JUNCTION; DOWN REGULATION; DRUG EFFECT; HEART; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; UPREGULATION;

ANIMALS; CELL COMMUNICATION; CONNEXINS; DOWN-REGULATION; GAP JUNCTIONS; HEART; HUMANS; OLIGOPEPTIDES; PHOSPHORYLATION; UP-REGULATION;

EID: 33744473829     PISSN: 00652326     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000092565     Document Type: Review

References (113)

1. Hervé JC, Sarrouilhe D: Protein phosphatase modulation of the intercellular junctional communication: importance in cardiac myocytes. Prog Biophys Mol Biol 2005, in press.
2. Lampe PD, Lau AF: The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004;36:1171-1186.
3. Cruciani V, Mikalsen SO: Connexins, gap junctional intercellular communication and kinases. Biol Cell 2002;94:433-443.
4. Doble BW, Chen Y, Bose DG, Litchfield DW, Kardami E: Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996;79:647-658.
5. 2+-independent mechanism. Pflügers Arch 2003;447:181-194.
6. Warn-Cramer BJ, Lau AF: Regulation of gap junctions by tyrosine protein kinases. Biochim Biophys Acta 2004;1662:81-95.
7. Sugiura H, Toyama J, Tsuboi N, Kamiya K, Kodama I: ATP directly affects gap junctional conductance between paired ventricular myocytes isolated from guinea pig heart. Circ Res 1990;66:1095-1102.
8. Kwak BR, Jongsma HJ: Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 1996;157:93-99.
9. Yogo K, Ogawa T, Akiyama M, Ishida N, Takeya T: Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells. FEBS Lett 2002;531:132-136.
10. Verrecchia F, Hervé JC: Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes. Am J Physiol 1997;272:C875-C885.
11. Doble BW, Ping P, Kardami E: The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 2000;86:293-301.
12. Dhein S: Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res 2004;62:287-298.
13. Turner MS, Haywood GA, Andreka P, You L, Martin PE, Evans WH, Webster KA, Bishopric NH: Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels. Circ Res 2004;95:726-733.
14. Dhein S, Weng S, Grover R, Tudyka T, Gottwald M, Schaefer T, Polontchouk L: Protein kinase Cα mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Commun Adhes 2001;8:257-264.
15. Spray DC, Burt JM. Structure-activity relations of the cardiac gap junction channel. Am J Physiol 1990;258:C195-C205.
16. Kwak BR, Saez JC, Wilders R, Chanson M, Fishman GI, Hertzberg EL, Spray DC, Jongsma HJ: Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels. Pflügers Arch 1995;430:770-778.
17. Bastide B, Hervé JC, Délèze J: The uncoupling effect of diacylglycerol on gap junctional communication of mammalian heart cells is independent of protein kinase C. Exp Cell Res 1994;214:519-527.
18. Münster PN, Weingart R: Effects of phorbol ester on gap junctions of neonatal rat heart cells. Pflügers Arch 1993;423:181-188.
19. Rouet-Benzineb P, Mohammadi K, Pérennec J, Poyard M, Bouanani Nel-H, Crozatier B: Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 1996;79:153-161.
20. Cooper CD, Lampe PD: Casein kinase 1 regulates connexin-43 gap junction assembly. J Biol Chem 2002;277:44962-44968.
21. Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS, Wang Y: Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem 2004;279:15330-15338.
22. Ai X, Pogwizd SM: Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 2005;96:54-63.
23. Duthe F, Plaisance I, Sarrouilhe D, Hervé JC: Endogenous protein phosphatase 1 runs down gap junctional communication of rat ventricular myocytes. Am J Physiol 2001;281:C1648-C1656.
24. Hervé JC, Plaisance I, Loncarek J, Duthe F, Sarrouilhe D: Is the junctional uncoupling elicited in rat ventricular myocytes by some dephosphorylation treatments due to changes in the phosphorylation status of Cx43? Eur Biophys J 2004;33:201-210.
25. Jeyaraman M, Tanguy S, Fandrich RR, Lukas A, Kardami E: Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol Cell Biochem 2003;242:129-134.
26. Kondo RP, Wang SY, John SA, Weiss JN, Goldhaber JI: Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 2000;32:1859-1872.
27. De Mello WC: Effects of intracellular injection of calcium and strontium on cell communication in heart. J Physiol 1975;250:231-245.
28. Noma A, Tsuboi N: Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea-pig. J Physiol 1987;382:193-211.
29. Rüdisüli A, Weingart R: Electrical properties of gap junction channels in guinea pig ventricular cell pairs revealed by exposure to heptanol. Pflügers Arch 1989;415:12-21.
30. i on nexal membrane resistance. Pflügers Arch 1987;409:394-402.
31. Reber WR, Weingart R: Ungulate cardiac Purkinje fibers: the influence of intracellular pH on the electrical cell-to-cell coupling. J Physiol 1982;328:87-104.
32. 2+. Am J Physiol 1987;253:C607-C609.
33. Firek L, Weingart R: Modification of gap junction conductance by divalent cations and protons in neonatal rat heart cells. J Mol Cell Cardiol 1995;27:1633-1643.
34. Hermans MMP, Kortekaas P, Jongsma HJ, Rook MB: pH sensitivity of the cardiac gap junction proteins, connexin 45 and 43. Pflügers Arch 1995;431:138-140.
35. Liu S, Taffet S, Stoner L, Delmar M, Vallano ML, Jalife J: A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length. Biophys J 1993;64:1422-1433.
36. Morley GE, Taffet SM, Delmar M: Intramolecular interactions mediate pH regulation of connexin 43 channels. Biophys J 1996;70:1294-1302.
37. De Mello WC: Influence of the sodium pump on intercellular communication in heart fibres: effect of intracellular injection of sodium ion on electrical coupling. J Physiol 1976;263:171-197.
38. Weingart R, Maurer P: Cell-to-cell coupling studied in isolated ventricular cell pairs. Experientia 1987;43:1091-1094.
39. Burt JM, Massey KD, Minnich BN: Uncoupling of cardiac cells by fatty acids: structure-activity relationships. Am J Physiol 1991;260:C439-C448.
40. Delmar M, Michaels DC, Johnson T, Jalife J: Effects of increasing intercellular resistance on transverse and longitudinal propagation in sheep epicardial muscle. Circ Res 1987;60:780-785.
41. Dhein S, Krüsemann K, Schaefer T: Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol 1999;128:1375-1384.
42. Takens-Kwak BR, Jongsma HJ, Rook MB, Van Ginneken AC: Mechanism of heptanol-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study. Am J Physiol 1992;262:C1531-C1538.
43. Dhein S, Hammerrath SB: Aspects of the intercellular communication in aged hearts: effects of the gap junction uncoupler palmitoleic acid. Naunyn Schmiedebergs Arch Pharmacol 2001;364:397-408.
44. Schmilinsky-Fluri G, Valiunas V, Willi M, Weingart R: Modulation of cardiac gap junctions: the mode of action of arachidonic acid. J Mol Cell Cardiol 1997;29:1703-1713.
45. Burt JM, Spray DC: Volatile anesthetics block intercellular communication between neonatal rat myocardial cells. Circ Res 1989;65:829-837.
46. He DS, Burt JM: Mechanism and selectivity of the effects of halothane on gap junction channel function. Circ Res 2000;86:E104-E109.
47. Chaytor AT, Martin PE, Evans WH, Randall MD, Griffith TM: The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol 1999;520:539-550.
48. Allen T, Iftinca M, Cole WC, Plane F: Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. J Physiol 2002;545:975-986.
49. Takens-Kwak BR, Jongsma HJ: Cardiac gap junctions: three distinct channel conductances and their modulation by phosphorylating treatments. Pflügers Arch 1992;422:198-200.
50. Taylor HJ, Chaytor AT, Edwards DH, Griffith TM: Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries. Biochem Biophys Res Comm 2001;283:583-589.
51. De Mello WC: Atrial natriurectic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J Cardiovasc Pharmacol 1998;32:75-79.
52. De Mello WC: Influence of alpha-adrenergic-receptor activation on junctional conductance in heart cells: interaction with beta-adrenergic agonists. J Cardiovasc Pharmacol 1997;29:273-277.
53. De Mello WC: Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J Cardiovasc Pharmacol 1994;23:640-646.
54. Dostal DE, Rothblum KN, Chernin MI, Cooper GR, Baker MK: Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am J Physiol 1992;263:C838-C850.
55. Suarez S, Ballmer-Hofer K: VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 2001;114:1229-1235.
56. Popp R, Brandes RP, Ott G, Busse R, Fleming I: Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Cire Res 2002;90:800-806.
57. 2. J Biol Chem 1999;274:35562-35570.
58. Brandes RP, Popp R, Ott G, Bredenkötter D, Wallner C, Busse R, Fleming I: The extracellular regulated kinases (ERK) 1/2 mediate cannabinoid-induced inhibition of gap junctional communication in endothelial cells. Br J Pharmacol 2002;136:709-716.
59. Harks EG, de Roos AD, Peters PH, de Haan LH, Brouwer A, Ypey DL, van Zoelen EJ, Theuvenet AP: Fenamates: a novel class of reversible gap junction blockers. J Pharmacol Exp Ther 2001;298:1033-1041.
60. Dhein S, Tudyka T: The therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs 1995;49:851-855.
61. De Mello WC: Impaired regulation of cell communication by beta-adrenergic receptor activation in the failing heart. Hypertension 1996;27:265-268.
62. Aonuma S, Kohama Y, Akai K, et al. Komiyama Y, Nakajima S, Wakabayashi M, Makino T: Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull (Tokyo) 1980;28:3332-3339.
63. Aonuma S, Kohama Y, Makino T, Fujisawa Y: Studies of heart. XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J Pharmacobiodyn 1982;5:40-48.
64. Dhein S: Peptides acting at gap junctions. Peptides 2002;23:1701-1709.
65. Dhein S, Manicone N, Müller A, Gerwin R, Ziskoven U, Irankhahi A, Minke C, Klaus W: A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study. Naunyn Schmiedebergs Arch Pharmacol 1994;350:174-184.
66. Müller A, Gottwald M, Tudyka T, Linke W, Klaus W, Dhein S: Increase in gap junction conductance by an antiarrhythmic peptide. Eur J Pharmacol 1997;327:65-72.
67. Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S: Pharmacological modulation of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 2002;16:1114-1116.
68. Grover R, Dhein S: Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectroscopy. Peptides 1998;19:1725-1729.
69. Grover R, Dhein S: Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides 2001;22:1011-1021.
70. Kjolbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS: Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 2003;306:1191-1199.
71. Dhein S, Larsen BD, Petersen JS: Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarisation. Naunyn Schmiedebergs Arch Pharmacol 2003;367(suppl):R94.
72. Xing D, Kjolbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH, Martins JB: ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 2003;14:510-520.
73. De Mello WC, Thormählen D: Effect of tedisamil on cell communication, impulse propagation, and excitability of the failing heart. Eur J Pharmacol 1999;372:241-246.
74. de Wit C, Esser N, Lehr HA, Bolz SS, Pohl U: Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilatation in the hamster microcirculation. Am J Physiol 1999;276:H1527-H1534.
75. Zhang YW, Morita I, Yao XS, Murota S: Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity. Prostaglandins Leukot Essent Fatty Acids 1999;61:33-40.
76. Moore LK, Burt JM: Selective block of gap junction channel expression with connexin-specific antisense oligonucleotides. Am J Physiol 1994;267:C1371-C1380.
77. Darrow BJ, Fast VG, Kléber AG, Beyer EC, Saffitz JE: Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ Res 1996;79:174-183.
78. Salameh A, Polontchouk L, Hagendorff A, Dhein S, Pfeiffer D: Protein kinase A and C regulate synthesis of the gap junction protein connexin43. FASEB J 2001;15(suppl):711.9.
79. Polontchouk L, Ebelt B, Jackels M, Dhein S: Chronic effects of endothelin-1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 2002;16:87-89.
80. Peters NS: New insights into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischaemic and hypertrophied hearts. Clin Sci (Lond) 1996;90:447-452.
81. Doble BW, Kardami E: Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol Cell Biochem 1995;143:81-87.
82. Rohr S: Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res 2004;62:309-322.
83. Lerner DL, Chapman Q, Green KG, Saffitz JE: Reversible down-regulation of connexin43 expression in acute cardiac allograft rejection. J Heart Lung Transplant 2001;20:93-97.
84. Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A: Downregulation of connexin43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999;11:216-224.
85. Fernandez-Cobo M, Gingalewski C, DeMaio A: Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock 1998;10:97-102.
86. Salameh A, Polontchouk L, Dhein S, Hagendorff A, Pfeiffer D: Chronic regulation of the expression of the gap junction protein connexin 43 in transfected HeLa cells. Naunyn Schmiedebergs Arch Pharmacol 2003;368:33-40.
87. Salameh A, Polonchouk L, Hagendorff A, Dhein S, Pfeiffer D: On the chronic regulation of gap junction protein connexin43 (Cx43) expression. Br J Pharmacol 2001;133(suppl):215P.
88. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ: Tumor necrosis factor alpha alters the expression of connexin43, connexin40 and connexin37 in human umbilical vein endothelial cells. Cytokine 1998;10:258-264.
89. Liu MY, Hattori Y, Sato A, Ichikawa R, Zhang XH, Sakuma I: Ovariectomy attenuates hyperpolarization and relaxation mediated by endothelium-derived hyperpolarizing factor in female rat mesenteric artery: a concomitant decrease in connexin-43 expression. J Cardiovasc Pharmacol 2002;40:938-948.
90. Wang TL, Tseng YZ, Chang H: Regulation of connexin43 gene expression by cyclical mechanical stretch in neonatal rat cardiomyocytes. Biochem Biophys Res Commun 2000;267:551-557.
91. Shyu KG, Chen CC, Wang BW, Kuan P: Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes. J Mol Cell Cardiol 2001;33:691-698.
92. Pimentel RC, Yamada KA, Kleber AG, Saffitz JE: Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res 2002;90:671-677.
93. Lauf U, Giepmans BN, Lopez P, Braconnot S, Chen SC, Falk MM: Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc Natl Acad Sci USA 2002;99:10446-10451
94. Puranam KL, Laird DW, Revel JP: Trapping an intermediate form of connexin43 in the Golgi. Exp Cell Res 1993;206:85-92.
95. Musil LS, Goodenough DA: Biochemical analysis of connexon assembly; in Kanno Y, Kataoka K, Shiba Y, Shibata Y, Shimazu T (eds): Intercellular Communication through Gap Junctions. Progress in Cell Research. Amsterdam, Elsevier, 1995, vol 4, pp 327-330.
96. Warner A, Clements DK, Parikh S, Evans WH, DeHaan RL: Specific motifs in the external loops of connexin proteins can determine gap junction formation between chick heart myocytes. J Physiol 1995;488:721-728.
97. Chaytor AT, Evans WH, Griffith TM: Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J Physiol 1997;503:99-110.
98. Kwak BR, Jongsma HJ: Selective inhibition of gap junction channel activity by synthetic peptides. J Physiol 1999;516:679-685.
99. Beyer EC, Berthoud VM: Gap junction synthesis and degradation as therapeutic targets. Curr Drug Targets 2002;3:409-416.
100. Laing JG, Tadros PN, Green K, Saffitz JE, Beyer EC: Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. Cardiovasc Res 1998;38:711-718.
101. Saez JC, Nairn AC, Czernik AJ, Fishman GI, Spray DC, Hertzberg EL: Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions. J Mol Cell Cardiol 1997;29:2131-2145.
102. Huang YS, Tseng YZ, Wu JC, Wang SM: Mechanism of oleic acid-induced gap junctional disassembly in rat cardiomyocytes. J Mol Cell Cardiol 2004;37:755-766.
103. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF: Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 2000;149:1503-1512.
104. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG: Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol 2001;155:1307-1318.
105. Shah MM, Martinez AM, Fletcher WH: The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Mol Cell Biochem 2002;238:57-68.
106. Warn-Cramer BJ, Lampe PD, Kurata WE, Kanemitsu MY, Loo LW, Eckhart W, Lau AF: Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J Biol Chem 1996;271:3779-3786.
107. John S, Cesario D, Weiss JN: Gap junctional hemichannels in the heart. Acta Physiol Scand 2003;179:23-31.
108. Kanemitsu MY, Lau AF: Epidermal growth factor stimulates the disruption of gap junctional communication and connexin43 phosphorylation independent of 12-0-tetradecanoylphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase. Mol Biol Cell 1993;4:837-848.
109. Swenson KI, Piwnica-Worms H, McNamee H, Paul DL: Tyrosine phosphorylation of the gap junction protein connexin43 is required for the pp60v-src-induced inhibition of communication. Cell Regul 1990;1:989-1002.
110. Lin R, Warn-Cramer BJ, Kurata WE, Lau AF: v-Src phosphorylation of connexin 43 on Tyr247 and Tyr265 disrupts gap junctional communication. J Cell Biol 2001;154:815-827.
111. Kanemitsu MY, Jiang W, Eckhart W: Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ 1998;9:13-21.
112. Lampe PD, Kurata WE, Warn-Cramer BJ, Lau AF: Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J Cell Sci 1998;111(Pt 6):833-841.
113. Cameron SJ, Malik S, Akaike M, Lerner-Marmarosh N, Yan C, Lee JD, Abe J, Yang J: Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem 2003;278:18682-18688.